Research News and Research

RSS

Fructose makes cells mature into fat cells in belly fat, study finds

Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.

22 Jun 2010

International team obtains genome sequence of human body louse

An international team has obtained the genome sequence of the human body louse (Pediculus humanus humanus), a parasite that feeds on the blood of its host and a vector of pathogens that cause diseases such as epidemic typhus, relapsing fever and trench fever.

22 Jun 2010

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.

22 Jun 2010

Pancreatic Cancer Action Network hosts fourth annual Pancreatic Cancer Advocacy Day

The Pancreatic Cancer Action Network today hosts its fourth annual Pancreatic Cancer Advocacy Day in Washington, D.C. Nearly 500 advocates, including patients, survivors and loved ones, from across the United States will meet with members of Congress to call for congressional action to ensure progress is made against the fourth leading cause of cancer death in our country by co-sponsoring the Pancreatic Cancer Research and Education Act.

22 Jun 2010

NCI awards GeneGo Phase II SBIR grant for development of MetaMiner(Oncology) platform

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they were awarded with a Phase II SBIR grant from the National Cancer Institute (NCI) for further development of an analytical platform for translational research and data analysis in oncology.

22 Jun 2010

Tobii Technology announces launch of cost-effective eye tracking system

Tobii Technology, the global market leader in eye tracking, today announces the launch of Tobii Glasses™ a revolutionary, cost-effective eye tracking system. Tobii Glasses will help researchers in commercial, scientific, and government organisations to gain greater levels of insight into the preferences, reactions and personal experiences of people in a natural environment.

22 Jun 2010

First Edition: June 22, 2010

In this Kaiser Health News consumer column, Michelle Andrews writes: "High-deductible health plans and the health savings accounts (HSAs) that link to them are becoming a familiar fixture on the insurance landscape, even though they get mixed reviews from many consumers and health-policy experts" (Kaiser Health News).

22 Jun 2010

Ohio Third Frontier helps drive innovation and opportunity in biomedical industry

Ohio Third Frontier, and the strategic investments made by the program to bolster Ohio's biomedical imaging industry, serve as a national model for success and are the primary reason behind Ohio's position as a national hub for innovation and opportunity in the thriving biomedical industry.

22 Jun 2010

New study that describes sequencing and analysis of body louse genome published

A global research team led by scientists from the J. Craig Venter Institute today published a new study in the Proceedings of the National Academy of Sciences describing the sequencing and analysis of the body louse genome. Lead author, Ewen Kirkness, Ph.D., JCVI, directed the sequencing and gene-finding efforts in the project. Detailed analysis of the genome was then conducted by a large international group of 71 scientists, coordinated by Barry Pittendrigh, University of Illinois, and Professor Evgeny Zdobnov, University of Geneva Medical School.

22 Jun 2010

CCBC fourth-quarter fiscal 2010 net revenues up 24.6%

China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced preliminary unaudited financial results for the fourth quarter and full year fiscal 2010.

22 Jun 2010

Diabetic individuals living in hot climate need increased 'heat awareness'

A new survey shows that diabetic individuals who live in a hot climate have important gaps in their "heat awareness," or knowledge about proper diabetes self-care in hot weather, even though diabetes raises their risk of heat illness. The results of "Diabetes in the Desert: What Do Patients Know About the Heat?" will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

S1 registration statement of Kraig Biocraft Laboratories declared effective

Kraig Biocraft Laboratories, Inc., a biotechnology company focused on the development of commercially significant high performance polymers and technical fiber including spider silk, is very pleased to announce that its S1 registration statement has been declared effective. The Company filed the S1 registration statement in October of 2009 and has been working diligently over the last nine months to obtain this clearance.

22 Jun 2010

Complimentary analyst briefing on the potential of European remote patient monitoring market

Across Europe, governments have realized the need to introduce remote monitoring into the mainstream of healthcare services. Currently, the market experiences heavy investment regarding the development of various patient monitoring systems using information and communication technology and enabling the remote monitoring of a patient.

22 Jun 2010

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria.

22 Jun 2010

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.

22 Jun 2010

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has commenced a Phase I/IIA human clinical trial for a new recombinant Lipase.

22 Jun 2010

New legal, ethical framework needs to be placed around banking of human biological material: Review

A lawyer and researcher at the Johns Hopkins Berman Institute of Bioethics says a new legal and ethical framework needs to be placed around the donation and banking of human biological material, one that would more clearly define the terms of the material's use - and address donor expectations before research begins.

22 Jun 2010

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.

22 Jun 2010

Improving health care for Saskatchewan patients remains a challenge: HQC report

In October 2008 the province's Health Quality Council released its first "state of health care quality" report, called Quality Insight. Key messages in that inaugural report were that limited access to timely data and the absence of an electronic health record were making it hard for HQC, health providers, and system leaders to improve health care for Saskatchewan patients.

22 Jun 2010

Most Americans view paid sick days as basic worker right

Paid sick leave is a benefit prized by American workers but frequently missing on the job — a situation that leads to serious consequences, a new study released Monday by the National Opinion Research Center at the University of Chicago shows.

22 Jun 2010

Research News and Research

Fructose makes cells mature into fat cells in belly fat, study finds

International team obtains genome sequence of human body louse

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Pancreatic Cancer Action Network hosts fourth annual Pancreatic Cancer Advocacy Day

NCI awards GeneGo Phase II SBIR grant for development of MetaMiner(Oncology) platform

Tobii Technology announces launch of cost-effective eye tracking system

First Edition: June 22, 2010

Ohio Third Frontier helps drive innovation and opportunity in biomedical industry

New study that describes sequencing and analysis of body louse genome published

CCBC fourth-quarter fiscal 2010 net revenues up 24.6%

Diabetic individuals living in hot climate need increased 'heat awareness'

S1 registration statement of Kraig Biocraft Laboratories declared effective

Complimentary analyst briefing on the potential of European remote patient monitoring market

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

New legal, ethical framework needs to be placed around banking of human biological material: Review

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Improving health care for Saskatchewan patients remains a challenge: HQC report

Most Americans view paid sick days as basic worker right

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence